Medilink East Midlands

XenoGesis shortlisted as a finalist for the Medilink East Midlands export award

XenoGesis has been shortlisted as a finalist for the 2019 Medilink East Midlands export award.

In recognition of XenoGesis experiencing a 78% increase in its exports and now having over half of its revenue coming from overseas clients, the company has been shortlisted for the 2019 Medilink East Midlands export award.

In the financial year ending March 2019, 50% of all its revenue came from overseas clients.

Commenting on the export growth, Richard Weaver, Founder and CEO of XenoGesis, said: “The international growth we have seen highlights the attractive proposition the UK has to offer, whether it is a lack of expertise locally in overseas markets or the wealth of scientific knowledge and expertise in the UK, we are definitely seeing a marked increase in international businesses turning to us for advice and support.

“We are delighted to have been shortlisted in the export category and look forward to joining the finalists on the 5 December.”

The Medilink East Midlands Business Awards will take place on Thursday 5 December at the Radisson Blu Hotel, East Midlands Airport.

The black tie event will be hosted by stand-up comedian Jimmy McGhie and is set to be an exciting evening of celebration with over 150 industry professionals expected to attend.

 

If you’d like to get in touch with one of our scientists, please click here!